Discovery of a prominent dual-target DDR1/EGFR inhibitor aimed DDR1/EGFR-positive NSCLC.
Wang X, Lu Y, Chen S, Zhu Z, Fu Y, Zhang J, He J, Huang L, Luo L, Guo W, Xu Z, Xie Z, Xu X, Zhang Y, Ye F, Ma S.
Wang X, et al. Among authors: luo l.
Bioorg Chem. 2024 May 27;149:107500. doi: 10.1016/j.bioorg.2024.107500. Online ahead of print.
Bioorg Chem. 2024.
PMID: 38823310